OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) Director Thomas Kosasa bought 268,817 shares of the firm’s stock in a transaction on Monday, May 18th. The shares were acquired at an average price of $0.93 per share, for a total transaction of $249,999.81. Following the transaction, the director owned 16,930,144 shares in the company, valued at approximately $15,745,033.92. This represents a 1.61% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Thomas Kosasa also recently made the following trade(s):
- On Thursday, April 23rd, Thomas Kosasa bought 280,898 shares of OneMedNet stock. The shares were acquired at an average price of $0.89 per share, for a total transaction of $249,999.22.
OneMedNet Stock Up 6.4%
Shares of NASDAQ:ONMD opened at $0.90 on Friday. The company’s 50 day moving average price is $0.90 and its two-hundred day moving average price is $1.05. OneMedNet Corporation has a 12-month low of $0.31 and a 12-month high of $4.22. The firm has a market cap of $49.16 million, a PE ratio of -12.90 and a beta of 1.25.
Institutional Trading of OneMedNet
A number of hedge funds have recently added to or reduced their stakes in the stock. Correct Capital Wealth Management acquired a new stake in OneMedNet in the third quarter valued at approximately $4,910,000. Exencial Wealth Advisors LLC boosted its position in OneMedNet by 1.3% in the fourth quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock valued at $4,009,000 after buying an additional 45,401 shares in the last quarter. State Street Corp boosted its position in OneMedNet by 41.5% in the fourth quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after buying an additional 34,200 shares in the last quarter. Jane Street Group LLC acquired a new stake in OneMedNet in the fourth quarter valued at approximately $119,000. Finally, Virtu Financial LLC acquired a new stake in OneMedNet in the fourth quarter valued at approximately $48,000. Institutional investors and hedge funds own 0.95% of the company’s stock.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen lowered shares of OneMedNet from a “hold” rating to a “sell” rating in a research report on Saturday. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, OneMedNet has an average rating of “Sell”.
Read Our Latest Stock Analysis on OneMedNet
OneMedNet Company Profile
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
Recommended Stories
- Five stocks we like better than OneMedNet
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
